Clinical Trial Management System Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)

Global Clinical Trial Management System Market is expected to reach $2.45 billion by the end of 2024 growing at a CAGR of around 12.8% from 2018 to 2024. A clinical trial management system (CTMS) is a system used by Pharmaceutical and Biotechnology industries to manage clinical trials in clinical research. The system maintains and oversees the planning, performing and reporting functions, along with participant contact information, tracking deadlines and many more.

Global Clinical Trial Management System Market Share:

Based on Mode of Delivery, Web-based sub-segment will represent a significant market, expanding at a robust CAGR of 15.2%. Based on a component, software sub-segment will attain a value of US$ 1.28 Billion by the end of the forecast period. The pharmaceutical industry is the most significant end-user of clinical trial management systems, and CROs sub-segment is expected to register the fastest CAGR throughout the forecast period.

Global Clinical Trial Management System Market Size:

North America will remain a dominant segment and expand at a CAGR of nearly 13.8%. This regional market was valued at US$ 1.3 Billion in 2018 and is predicted to reach US$ 1.9 Billion by 2024 end. As the clinical trial market has gradually been shifting to the Asia Pacific due to several legal and regulatory measures, and patent expiration laws. China and India are expected to grow into lucrative markets for clinical trial management systems. The European market will also reflect significant growth.

Global Clinical Trial Management System Market Growth:

Increasing prevalence of chronic diseases will spur the demand for effective and efficient management of data, documentation, and hospital information within medical organisations. This is expected to be a key factor propelling the growth of the CTMS market. The increasing number of healthcare service providers and exploding number of healthcare end-users will further accelerate CTMS adoption in the market. High accuracy of the information provided by clinical trial management systems is foreseen to be a significant driver of market growth.

Global Clinical Trial Management System Market Industry Analysis:

On basis of Delivery Mode, The market is segmented into Web-based Clinical Trial Management System, On-Premise Clinical Trial Management System and Cloud-based Clinical Trial Management System. On basis of Components, The market is segmented into Software, Hardware and Services. On basis of End User, The market is segmented into Pharmaceuticals & Biotechnology Companies and Healthcare Providers: Research Hospitals, Clinics, Academic Medical Centres and Cancer Centres. On basis of Type, The market is segmented into Site based Clinical Trial Management System and Licensed Enterprise based Clinical Trial Management System. On basis of Applications, The market is segmented into Patient Management Solutions, Site Management Solutions, Data Management Solutions and Document Management Solutions and By Region, it is segmented into North America, Europe, Asia Pacific and Rest of the World.

Global Clinical Trial Management System Market Outlook:

Integration of Hospital information system (HIS) and Clinical trial management system enables accurate documentation. The emergence of global clinical organisations provides users with most relevant and specific information by maintaining a centralised clinical trial management database.

Global Clinical Trial Management System Market Trends:

Forte, an industry-leading developer of clinical research solutions, has been named to the 2017 Best Places to Work by Madison Magazine. Forte is ranked third of the top 10 largest companies. Bio-Optronics and Complion Announced the Integration to Unify Best-in-Class CTMS and eRegulatory Solutions for Clinical Research Organizations.

Global Clinical Trial Management System Market Research report includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• Bio-Optronics
• Merge Healthcare
• Forte Research Systems
• Parexel
• BioClinica